Immune Monitoring of Paediatric Patients Infected with , and Coinfected.

In 2021, 273 Rocky Mountain spotted fever cases were reported nationwide in Mexico. In Chihuahua City, fourteen samples were obtained from children suspected of rickettsial infection. The analysis of samples (January to December 2021) showed prevalence rates of 28.

Antimicrobial and Immunomodulatory Effects of Selected Chemokine and Antimicrobial Peptide on Cytokine Profile during Typhimurium Infection in Mouse.

The antimicrobial and immunomodulatory capacities of the peptide Css54 and the chemokine MCP-1 were tested. The first, a peptide isolated from the venom of the scorpion was synthesized chemically. In contrast, the second is a monocyte chemoattractant expressed as a recombinant protein in our lab.

Immunomodulatory Responses of Two Synthetic Peptides against Typhimurium Infection.

In vitro assays of phagocytic activity showed that the peptide Pin2[G] stimulates phagocytosis in BMDM cells from 0.15 to 1.25 μg/mL, and in RAW 264.

Two-year clinical performance of Clearfil SE and Clearfil S3 in restoration of unabraded non-carious class V lesions.

This study was undertaken to evaluate the two-year clinical performance of a self-etching primer and a self-etching adhesive, both of which employ the same acidic monomer. Forty pairs of restorations of AP-X hybrid resin composite (Kuraray Co, Ltd, Osaka, Japan) were placed in caries-free cervical erosion/abfraction lesions. Based on insensitivity to air, the dentin in 62% of these lesions was considered to be sclerotic.

Two-year clinical performance of Class V resin-modified glass-lonomer and resin composite restorations.

While a one-year report had been previously published, this study was undertaken to evaluate the clinical performance and appearance of a resin-modified glass ionomer and a resin composite over two years. Thirty-seven pairs of restorations of FujI II LC and Z 250/Single Bond were placed in caries-free cervical erosion/abfraction lesions without tooth preparation. Restorations were clinically evaluated at baseline, 6, 12, 18 and 24 months using modified Ryge/USPHS criteria.